Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

348 ARTÍCULOS , VIENDO DEL 256 AL 270

Advances in Aβ plaque detection and the value of knowing: overcoming challenges to improving patient outcomes in Alzheimer's disease

Jovalekic A, Bullich S, Catafau A, de Santi S.

Neurodegener Dis Manag. 2016 Dec;6(6):491-497. doi: 10.2217/nmt-2016-0026. Epub 2016 Nov 4.

Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review

Bemelmans SA, Tromp K, Bunnik EM, Milne RJ, Badger S, Brayne C, Schermer MH, Richard E.

Alzheimers Res Ther. 2016 Nov 10;8(1):46. doi: 10.1186/s13195-016-0212-z.

Serum Testosterone and Cognitive Function in Ageing Male: Updating the Evidence

Giagulli VA, Guastamacchia E, Licchelli B, Triggiani V.

Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):22-30. doi: 10.2174/1872214810999160603213743.

Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive Impairment

Kobayashi N, Shinagawa S, Nagata T, Shimada K, Shibata N, Ohnuma T, Kasanuki K, Arai H, Yamada H, Nakayama K, Kondo K.

PLoS One. 2016 Dec 19;11(12):e0168816. doi: 10.1371/journal.pone.0168816. eCollection 2016.

Vascular biomarkers to predict response to exercise in Alzheimer's disease: the study protocol

Li D, Thomas R, Tsai MY, Li L, Vock DM, Greimel S, Yu F.

BMJ Open. 2016 Dec 30;6(12):e011054. doi: 10.1136/bmjopen-2016-011054.

Clinical Consensus Guidelines on the Application of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: Recommendations of the Irish Network for Biomarkers in Neurodegeneration

Miller AM, Begley E, Coen R, Doyle M, Dunne J, Hutchinson S, Kennelly SP, Kenny RA, Killeen RP, Lynch A, O'Dwyer S, O'Neill C, O'Sullvan SS, Rowan MJ, Sheehy N, McGuigan C, Lawlor BA.

Ir Med J. 2016 Dec 12;109(10):483.

What does the broken brain say to the neuroscientist? Oscillations and connectivity in schizophrenia, Alzheimer's disease, and bipolar disorder

Başar E, Schmiedt-Fehr C, Mathes B, Femir B, Emek-Savaş DD, Tülay E, Tan D, Düzgün A, Güntekin B, Özerdem A, Yener G, Başar-Eroğlu C.

Int J Psychophysiol. 2016 May;103:135-48. doi: 10.1016/j.ijpsycho.2015.02.004. Epub 2015 Feb 7.

Salvia miltiorrhiza: A source for anti-Alzheimer's disease drugs

Zhang XZ, Qian SS, Zhang YJ, Wang RQ.

Pharm Biol. 2016;54(1):18-24. doi: 10.3109/13880209.2015.1027408. Epub 2015 Apr 10.

Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation

Kudoh C, Arita R, Honda M, Kishi T, Komatsu Y, Asou H, Mimura M.

Psychogeriatrics. 2016 Mar;16(2):85-92. doi: 10.1111/psyg.12125. Epub 2015 Apr 27.

Neuronal histamine and cognitive symptoms in Alzheimer's disease

Zlomuzica A, Dere D, Binder S, De Souza Silva MA, Huston JP, Dere E.

Neuropharmacology. 2016 Jul;106:135-45. doi: 10.1016/j.neuropharm.2015.05.007. Epub 2015 May 27.

Safety and pharmacokinetics of bapineuzumab in a single ascending-dose study in Japanese patients with mild to moderate Alzheimer's disease

Arai H, Umemura K, Ichimiya Y, Iseki E, Eto K, Miyakawa K, Kirino E, Shibata N, Baba H, Tsuchiwata S.

Geriatr Gerontol Int. 2016 May;16(5):644-50. doi: 10.1111/ggi.12516. Epub 2015 Jun 4.

Disease state changes and safety of long-term donepezil hydrochloride administration in patients with Alzheimer's disease: interim results from the long-term, large-scale J-GOLD study in Japan

Arai H, Sumitomo K, Sakata Y, Daidoji K, Takase T, Toyoda T.

Psychogeriatrics. 2016 Mar;16(2):107-15. doi: 10.1111/psyg.12130. Epub 2015 Jun 26.

Early psychosocial intervention does not delay institutionalization in persons with mild Alzheimer disease and has impact on neither disease progression nor caregivers' well-being: ALSOVA 3-year follow-up

Koivisto AM, Hallikainen I, Välimäki T, Hongisto K, Hiltunen A, Karppi P, Sivenius J, Soininen H, Martikainen J.

Int J Geriatr Psychiatry. 2016 Mar;31(3):273-83. doi: 10.1002/gps.4321. Epub 2015 Jul 14.

Neurosyphilis mimicking young-onset Alzheimer's disease: a case report explaining the pitfalls of FDG-PET

Verjans S, Van Laere K, Vandenberghe R.

Acta Neurol Belg. 2016 Jun;116(2):207-10. doi: 10.1007/s13760-015-0508-y. Epub 2015 Jul 16.

Current and novel therapeutic molecules and targets in Alzheimer's disease

Kumar A, Nisha CM, Silakari C, Sharma I, Anusha K, Gupta N, Nair P, Tripathi T, Kumar A.

J Formos Med Assoc. 2016 Jan;115(1):3-10. doi: 10.1016/j.jfma.2015.04.001. Epub 2015 Jul 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias